Early response to infusional chemotherapy is an independent prognostic factor in newly-diagnosed IgG and IgA multiple myeloma

被引：0
|
作者：
Sirohi, B
Powles, R
Kulkarni, S
Saso, R
Mehta, J
Singhal, S
Horton, C
Treleaven, J
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S244 / S244
页数：1
相关论文
共 50 条
  • [1] Early response to infusional chemotherapy is an independent prognostic factor in newly-diagnosed IgG and IgA multiple myeloma.
    Powles, R
    Sirohi, B
    Treleaven, J
    Singhal, S
    Kulkarni, S
    Saso, R
    Horton, C
    Mehta, J
    BLOOD, 2000, 96 (11) : 758A - 758A
  • [2] Maximal response to infusional chemotherapy prior to autotransplantation influences outcome of patients with newly-diagnosed multiple myeloma
    Sirohi, B
    Powles, R
    Kulkarni, S
    Chau, I
    Saso, R
    Lal, R
    Riggs, A
    Horton, C
    Treleaven, J
    BONE MARROW TRANSPLANTATION, 2001, 27 : S246 - S246
  • [3] Maximal response to infusional chemotherapy prior to autotransplantation influences outcome of patients with newly-diagnosed multiple myeloma.
    Powles, R
    Sirohi, B
    Treleaven, J
    Singhal, S
    Kulkarni, S
    Chau, I
    Saso, R
    Horton, C
    Lal, R
    Mehta, J
    BLOOD, 2000, 96 (11) : 292B - 293B
  • [4] Implications and Prognostic Impact of Mass Spectrometry in Patients with Newly-Diagnosed Multiple Myeloma
    Mai, Elias K.
    Huhn, Stefanie
    Miah, Kaya
    Poos, Alexandra M.
    Scheid, Christof
    Weisel, Katja
    Bertsch, Uta
    Munder, Markus
    Berlanga, Oscar
    Hose, Dirk
    Seckinger, Anja
    Jauch, Anna
    Blau, Igor Wolfgang
    Haenel, Mathias
    Salwender, Hans
    Benner, Axel
    Raab, Marc S.
    Goldschmidt, Hartmut
    Weinhold, Niels
    BLOOD, 2022, 140 : 2341 - 2343
  • [5] Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
    Elias K. Mai
    Stefanie Huhn
    Kaya Miah
    Alexandra M. Poos
    Christof Scheid
    Katja C. Weisel
    Uta Bertsch
    Markus Munder
    Oscar Berlanga
    Dirk Hose
    Anja Seckinger
    Anna Jauch
    Igor W. Blau
    Mathias Hänel
    Hans J. Salwender
    Axel Benner
    Marc S. Raab
    Hartmut Goldschmidt
    Niels Weinhold
    Blood Cancer Journal, 13
  • [6] Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
    Mai, Elias K.
    Huhn, Stefanie
    Miah, Kaya
    Poos, Alexandra M.
    Scheid, Christof
    Weisel, Katja C.
    Bertsch, Uta
    Munder, Markus
    Berlanga, Oscar
    Hose, Dirk
    Seckinger, Anja
    Jauch, Anna
    Blau, Igor W.
    Haenel, Mathias
    Salwender, Hans J.
    Benner, Axel
    Raab, Marc S.
    Goldschmidt, Hartmut
    Weinhold, Niels
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [7] Renal recovery is a favorable prognostic marker in patients with newly-diagnosed multiple myeloma
    Badea, M.
    Badea, D.
    Genuche, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 202 - 203
  • [8] VERBAL MEMORY PERFORMANCE AS EARLY PROGNOSTIC FACTOR IN NEWLY-DIAGNOSED EPILEPSY
    AIKIA, M
    KALVIAINEN, R
    RIEKKINEN, PJ
    NEUROLOGY, 1995, 45 (04) : A180 - A180
  • [9] Economic burden of early progression in newly-diagnosed multiple myeloma patients.
    Pandya, Shivani
    Clancy, Zoe
    Shrestha, Sulena
    Wang, Li
    Ni, Quanhong
    Baser, Onur
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Implication of impaired renal function at the time of initiation of infusional chemotherapy (C-VAMP) in patients with newly-diagnosed myeloma.
    Sirohi, B
    Powles, R
    Singhal, S
    Treleaven, J
    Kulkarni, S
    Saso, R
    Horton, C
    Heming, D
    Mehta, J
    BLOOD, 2001, 98 (11) : 686A - 686A
12345